Agilent Technologies (A)Rep. Rob Bresnahan (PA08) disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

16 days

Disclosure lag

Traded

May 15, 2025

Disclosed

May 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 3, 2025CongressDisclosed sale of A — reported range $1,001 - $15,000
2. Mar 13, 2025CongressDisclosed sale of A — reported range $15,001 - $50,000
3. Mar 17, 2025InsiderOfficer sold ~$233K of A shares in the open market
4. Mar 20, 2025FDARecall: GenetiSure Dx Labeling Kit, REF: K1201-64105, contains human reference DNA female aliquot, REF5190-7317. A required kit for the GenetiSure Dx Postnatal assay (…
5. Mar 31, 2025InsiderDirector sold ~$212K of A shares in the open market
6. Apr 1, 2025CongressDisclosed partial sale of A — reported range $1,001 - $15,000
7. Apr 8, 2025CongressDisclosed sale of A — reported range $1,001 - $15,000
8. Apr 17, 2025CongressDisclosed purchase of A — reported range $15,001 - $50,000
9. May 12, 2025CongressDisclosed sale of A — reported range $15,001 - $50,000
10. May 15, 2025 · this disclosureCongressDisclosed purchase of A — reported range $1,001 - $15,000

What came next

1. Jun 17, 2025CongressDisclosed purchase of A — reported range $1,001 - $15,000
2. Jun 18, 2025InsiderDirector sold ~$904 of A shares in the open market
3. Jul 1, 2025InsiderCEO sold ~$177K of A shares in the open market
4. Jul 16, 2025CongressDisclosed sale of A — reported range $1,001 - $15,000
5. Aug 1, 2025InsiderCEO sold ~$227K of A shares in the open market
6. Aug 11, 2025FDARecall: Brand Name: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) Model/Catalog Number: GA60461-2 Software Version: Not applicable Prod…
7. Aug 11, 2025FDARecall: Brand Name: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) Model/Catalog Number: GA60461-2J Software Version: Not applicable Pro…
8. Aug 11, 2025FDARecall: Brand Name: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) Model/Catalog Number: GA60461-2CN Software Version: Not applicable Pr…
9. Aug 15, 2025FDAFDA device approval: MMR IHC Panel pharmDx (Dako Omnis)
10. Sep 2, 2025InsiderCEO sold ~$250K of A shares in the open market

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Agilent Technologies

For Agilent Technologies, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 21 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its A page.

Other recent filings by Rep. Rob Bresnahan (PA08)

• House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Dec 19, 2025
• House Clerk periodic transaction report at Gitlab (GTLB)Jul 8, 2025
• House Clerk periodic transaction report at Amazon (AMZN)Jul 8, 2025
• House Clerk periodic transaction report at AppLovin (APP)Jul 8, 2025
• House Clerk periodic transaction report at Atlassian (TEAM)Jul 8, 2025

The full history of Rep. Rob Bresnahan (PA08) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Agilent Technologies

• USAspending.gov award recordSep 29, 2026
• USAspending.gov award recordSep 28, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 144Sep 4, 2026
• USAspending.gov award recordAug 18, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its A page.